Idera Pharmaceuticals Inc Headquarters
Looking for information about Idera Pharmaceuticals Inc Headquarters? The links below have collected all the necessary data.
http://www.iderapharma.com/
Idera Pharmaceuticals Announces Corporate Updates. EXTON, Pa. , May 18, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera” or the… Read more . Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update. EXTON, Pa. , April 29, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera ...
https://www.iderapharma.com/contact-us/
Please direct all general questions regarding Idera to: Idera Pharmaceuticals 505 Eagleview Boulevard Suite 212 Exton, PA 19341 Telephone: 484-348-1600 For […]
https://www.crunchbase.com/organization/idera-pharmaceuticals
Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune
https://www.linkedin.com/company/idera-pharmaceuticals
Idera Pharmaceuticals is a clinical-stage biopharmaceutical company located in the western Philadelphia suburb of Exton. We are passionately focused …
https://www.idera.com/about/contactus
Austin, Texas IDERA Headquarters 10801 North Mopac Expressway Building 1, Suite 100 Austin, TX, 78759 Phone 512-226-8080 E-Fax Number: 512.226.8441
https://ir.iderapharma.com/news-releases/news-release-details/idera-pharmaceuticals-provides-corporate-update
Apr 08, 2019 · EXTON, Pa., April 10, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA), a clinical-stage biopharmaceutical company focused on the development, and ultimately the commercialization, of therapeutic drugs for both oncology and rare disease indications, today announced that Cristina Csimma, Pharm. D., M.H.P. and Michael Dougherty have been …
https://ir.iderapharma.com/news-releases/news-release-details/idera-pharmaceuticals-announces-corporate-organizational-changes
Sep 11, 2018 · - Bryant D. Lim appointed as General Counsel and Secretary of the Board of Directors - - Chief Financial Officer Louis J. Arcudi III departing the company related to company consolidation to Pennsylvania-. EXTON, Pa., Sept. 11, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of …
https://en.wikipedia.org/wiki/Idera_Software
Idera, Inc. (/ aɪ ˈ d ɪər ə /) is the parent company of a portfolio of brands that offer B2B software including database tools, application development tools, test management tools, and DevOps tools. It is headquartered in Houston, Texas and has offices in Australia, Austria, and the United Kingdom.It is owned by the private equity firms HGGC, Partners Group and TA Associates
https://ir.iderapharma.com/news-releases/news-release-details/biocryst-pharmaceuticals-and-idera-pharmaceuticals-announce
Jan 22, 2018 · For Idera Robert Doody Vice President, Investor Relations and Corporate Communications Office: 617-679-5515 Mobile: 484‐639‐7235 [email protected]. Media Contact for Idera and BioCryst Katie Engleman Pure Communications [email protected] 910-509-3977 Source: Idera Pharmaceuticals, Inc. Source: BioCryst Pharmaceuticals, Inc.
Have you found Idera Pharmaceuticals Inc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|